查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1470815

藥物分析測試外包市場：按服務、測試方法和最終用途分類 - 2024-2030 年全球預測

Pharmaceutical Analytical Testing Outsourcing Market by Services (Bioanalytical Testing, Method Development & Validation, Stability Testing), Testing Technique (Chromatography, Mass Spectrometry, Spectroscopy), End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年藥品分析測試外包市場規模為92.3億美元，預計2024年將達100.7億美元，2030年將達173億美元，複合年成長率為9.38%。

藥品分析測試外包是指由外部機構專門為製藥公司執行各種分析測試程序提供的專業服務。這種外包是製藥公司採取的一種策略方法，旨在提高成本效率、利用專業知識並從內部不具備的先進技術中獲益。藥物分析測試外包的需求是由以下因素推動的：對準確藥物驗證的監管要求不斷增加、需要先進分析方法的藥品複雜性不斷增加，以及製藥公司為專注於核心能力而進行的成本最佳化努力。儘管出現了預期的成長，但智慧財產權問題和遵守嚴格監管標準的需求可能會導致前置作業時間和成本增加，從而抑制市場成長。然而，人工智慧和高通量篩檢方法等技術進步正在為市場成長提供新的途徑。此外，個人化醫療和罕見疾病藥物的趨勢正在擴大專業分析測試服務的可能性，並為藥物分析測試外包市場創造重大商機。

主要市場統計
基準年[2023] 92.3億美元
預測年份 [2024] 100.7億美元
預測年份 [2030] 173億美元
複合年成長率（%） 9.38%

對生物分析測試服務的需求以確定服務藥物的功效和安全性

生物分析測試服務在臨床和非臨床環境中都至關重要。臨床生物分析測試是藥物開發過程中的重要步驟，涉及生物體液中藥物的定量測量。此評估對於確定臨床試驗中藥物化合物的功效和安全性至關重要。非臨床生物分析測試是藥物開發週期早期階段的重要組成部分。這涉及使用動物模型在體內或體外測試新藥物實體，以便在將其用於人類之前對該物質的安全性和生物活性進行初步評估。

在藥物分析測試領域，方法開發和驗證是確保結果準確性和可靠性的關鍵要素。萃取性和溶出方法的自訂製化開發和嚴格驗證對於評估藥品及其包裝材料的相容性至關重要。同樣，雜質方法的開發對於識別和量化可能影響產品安全性和功效的雜質至關重要。除此之外，技術諮詢還提供專家指導，以應對複雜的監管要求並最佳化分析程序以獲得可靠的結果。

穩定性測試是藥物品管的重要組成部分，可以深入了解藥物的保存期限並確保其在整個預期保存期限內保持安全有效。加速穩定性測試模擬長期環境影響以預測產品壽命，而原料藥測試則評估不同條件下的行為。光穩定性測試評估暴露於光如何影響藥品的穩定性，並確保暴露於光的藥品不會分解到不可接受的程度。穩定性方法驗證是一個徹底的分析過程，可確認分析程序是否適合檢測藥品的效力和純度的變化。此驗證證實特定的分析方法可以準確可靠地測量原料藥和藥品可能因分解而產生的變化。

檢測技術：層析法在有效分離和定量樣品中分析物的優勢

層析法是一種通用的分離技術，廣泛應用於製藥業，用於定量和鑑定混合物的成分以及精製藥物化合物。它因其高精度、分離複雜混合物的能力以及從分析到製備應用的擴充性而受到青睞。質譜分析是一種透過質荷比來辨識化合物的分析技術。該技術對於結構解析、微量成分鑑定和雜質分析至關重要。其高特異性和靈敏度使其成為藥物動力學、代謝研究和蛋白質體學的合適方法。光譜學涵蓋了基於光與物質相互作用的各種技術。在製藥工業中，它用於結構分析、化合物鑑定和濃度測定。

最終用途製造外包對各種困難測試服務的需求不斷增加

生物製藥和製藥部門包括參與藥品開發和製造的公司，包括生物來源（生物製藥）和化學合成藥物（藥品）。這些公司所需的分析測試服務包括純度評估、穩定性測試、生物分析測試、批次放行測試等。受託製造廠商（CMO）是一家以合約為基礎向其他製藥公司提供服務的公司，提供從藥物開發到藥品製造的全套服務。這些公司通常會外包分析測試，以保持法規遵循並確保產品質量，而無需投資昂貴的實驗室基礎設施。

區域洞察

美洲的藥物分析測試外包市場呈現強勁成長。製藥業和老牌外包公司的存在加強了這種成長。以美國食品藥物管理局(FDA) 為首的嚴格監管環境，以及對成本效率、創新和縮短時間日益成長的需求正在推動外包活動。在歐洲、中東和非洲地區，歐洲仍然是藥品分析測試外包市場的主要貢獻者。該市場受益於先進的醫療保健基礎設施、對藥品研發的大量投資以及該地區完善的法律規範。儘管規模小於歐洲，但在醫療保健投資增加以及對降低成本和利用當地專業知識的製藥外包興趣不斷成長的推動下，中東和非洲地區正在緩慢擴張。在中國和印度等新興國家的推動下，亞太地區市場正經歷快速成長。這些國家因其具有成本競爭力的勞動力、藥物分析專業化程度的提高以及對國際品質標準的遵守程度的提高而成為熱點。當地製藥商的擴張和醫療保健基礎設施領域外國投資的增加繼續為該地區的藥物分析測試外包服務創造新的機會。

FPNV定位矩陣

FPNV 定位矩陣對於評估藥物分析測試外包市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對藥物分析測試外包市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估及資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.藥物分析檢測外包市場規模及預測是多少？

2.藥物分析測試外包市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3.藥物分析測試外包市場的技術趨勢和法規結構是什麼？

4.藥物分析測試外包市場主要供應商的市場佔有率為何？

5.進入藥品分析檢測外包市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加藥物發現和開發的研究和開發
      • 藥物處方的複雜性以及需要遵守嚴格的監管標準
      • 藥物分析測試外包作為一種成本最佳化策略越來越受歡迎
    • 抑制因素
      • 分析設備和最先進設備的維護高成本
    • 機會
      • 藥物檢測程序的新技術進展
      • 加大醫藥產業投資力度
    • 任務
      • 智慧財產權問題
  • 市場區隔分析
    • 服務：對生物分析測試服務的需求，以確定藥物的功效和安全性
    • 測試技術：層析法的主要優點在於其能夠有效率地分離和定量樣品中的分析物
    • 最終用途：合約製造組織對廣泛且高度複雜的測試服務的需求不斷增加
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 藥物分析測試外包市場：依服務分類

  • 生物分析測試
  • 方法開發和檢驗
  • 穩定性測試

第7章依測試方法分類的藥物分析測試外包市場

  • 層析法
  • 質譜
  • 光譜學

第8章藥物分析測試外包市場：依最終用途

  • 生物製藥和藥品
  • 合約製造組織

第9章 北美、南美藥品分析測試外包市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太藥品分析測試外包市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲藥品分析測試外包市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Sterling Acuris 透過新收購擴展到製藥和分析測試領域
    • Eurofins 透過與日本Astellas Pharma 簽訂外包協議擴大生物製藥產品測試基地
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-A339DAEFAEE4

[195 Pages Report] The Pharmaceutical Analytical Testing Outsourcing Market size was estimated at USD 9.23 billion in 2023 and expected to reach USD 10.07 billion in 2024, at a CAGR 9.38% to reach USD 17.30 billion by 2030.

Pharmaceutical analytical testing outsourcing refers to the professional services provided by external organizations that specialize in performing various analytical testing procedures for pharmaceutical companies. This practice of outsourcing is a strategic approach adopted by pharmaceutical companies to attain cost efficiencies, access specialized expertise, and benefit from advanced technologies that they may not possess in-house. The demand for pharmaceutical analytical testing outsourcing is driven by factors such as increasing regulatory demands for precise drug validation, the rising complexity of drugs, which requires advanced analytical methods, and cost optimization efforts from pharmaceutical companies looking to focus on core competencies. Despite the growth prospects, intellectual property concerns and the need for compliance with stringent regulatory standards, which can lead to an increase in lead time and costs, act as a restraint for market growth. However, advancements in technology, such as AI and high-throughput screening methods, present new avenues for market growth. The trend towards personalized medicine and orphan drugs also opens up a potential for specialized analytical testing services, presenting significant opportunities for the pharmaceutical analytical testing outsourcing market.

KEY MARKET STATISTICS
Base Year [2023] USD 9.23 billion
Estimated Year [2024] USD 10.07 billion
Forecast Year [2030] USD 17.30 billion
CAGR (%) 9.38%

Services: Demand for bioanalytical testing services to determine efficacy and safety of pharmaceutical products

Bioanalytical testing services are essential for both clinical and non-clinical settings. Clinical bioanalytical testing is a critical phase in the drug development process, entailing the quantitative measurement of drugs in biological fluids. This evaluation is paramount for determining the efficacy and safety of pharmaceutical compounds in clinical trials. Non-clinical bioanalytical testing is an essential early-stage component of the drug development cycle. This involves the examination of new drug entities in vivo or in vitro in animal models to establish a preliminary assessment of the safety and biological activity of a substance before it is administered to humans.

In the realm of pharmaceutical analytical testing, method development and validation are critical components that ensure accuracy and reliability in results. Custom development and rigorous validation of methods for extractable and leachable are vital for assessing the compatibility between drug products and their packaging. Similarly, the development of an impurity method is crucial for identifying and quantifying potential impurities that could affect product safety and efficacy. Alongside this, technical consulting provides expert guidance to navigate complex regulatory requirements and optimize analytical procedures for robust outcomes.

Stability testing represents an integral part of pharmaceutical quality control, offering insights into a drug's shelf life and ensuring it remains safe and effective throughout its intended storage period. Accelerated stability testing simulates long-term environmental effects to predict a product's lifespan, while tests on the drug substance evaluate its behavior under varied conditions. Photostability testing assesses how exposure to light affects the stability of pharmaceutical products to ensure drug products do not degrade to an unacceptable degree when exposed to light. Stability indicating method validation is a thorough analytical process that confirms the suitability of analytical procedures for detecting changes in a drug's potency and purity. It involves the validation of specific methods to ensure they can accurately and reliably measure changes in the drug substances and products, which could result from degradation.

Testing Technique: Significant benefits of chromatography owing to its efficiency in separating and quantifying analytes in samples

Chromatography is a versatile separation technique extensively used in the pharmaceutical industry for quantifying and identifying the components of a mixture and purifying pharmaceutical compounds. It is preferred for its high precision, ability to separate complex mixtures, and scalability from analytical to preparative applications. Mass spectrometry offers an analytical technique that identifies compounds by their mass-to-charge ratio. This technique is indispensable for structural elucidation, identification of trace components, and impurity profiling. Its high specificity and sensitivity make it a suitable method for pharmacokinetics, metabolism studies, and proteomics. Spectroscopy encompasses a range of techniques based on the interaction of light with matter. In the pharmaceutical industry, it is used for structural analysis, compound identification, and concentration determination.

End-use: Growing need for a broad range of high-complexity testing services from contract manufacturing organizations

The Biopharmaceuticals & pharmaceuticals segment encompasses companies involved in the development and manufacturing of drugs, both biologically derived products (biopharmaceuticals) and chemically synthesized drugs (pharmaceuticals). Analytical testing services required by these entities include purity assessment, stability testing, bioanalytical testing, and batch-release testing, among others. Contract manufacturing organizations (CMOs) are companies that serve other pharmaceutical businesses on a contract basis to provide a comprehensive suite of services ranging from drug development to drug manufacturing. These organizations commonly outsource analytical testing to maintain regulatory compliance and ensure product quality without needing to invest in expensive laboratory infrastructure.

Regional Insights

The pharmaceutical analytical testing outsourcing market in the Americas is demonstrating robust growth. This growth is fortified by the presence of a pharmaceutical industry, along with well-established outsourcing companies. The stringent regulatory landscape, spearheaded by the U.S. Food and Drug Administration (FDA), and the increasing demand for cost-efficiency, innovation, and faster time-to-market are driving outsourcing activities. Europe remains a major contributor to the pharmaceutical analytical testing outsourcing market within the EMEA region. The market is benefiting from advanced healthcare infrastructure, significant investment in pharmaceutical R&D, and well-defined regulatory frameworks in the region. The Middle East and Africa, while smaller in comparison to Europe, are experiencing gradual expansions fueled by growing investment in healthcare sectors and a rising interest in pharmaceutical outsourcing to reduce costs and leverage regional expertise. The APAC market is experiencing rapid growth in pharmaceutical analytical testing outsourcing, backed by emerging economies such as China and India. These countries are becoming hotspots owing to their cost-competitive labor, growing expertise in pharma analytics, and increasing compliance with international quality standards. The expansion of local pharmaceutical manufacturers, coupled with increased foreign investments in healthcare infrastructure, continues to create new opportunities for pharmaceutical analytical testing outsourcing services in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Analytical Testing Outsourcing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Analytical Testing Outsourcing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Analytical Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Bio-Pharma, Alcami Corporation, AptarGroup, Inc., Ascendia Pharmaceuticals, BioAgilytix, Cambrex Corporation, Catalent, Inc, Charles River Laboratories International, Inc., Element Materials Technology, Eurofins Scientific SE, ICON PLC, Intertek Group PLC, Laboratory Corporation of America Holdings, LGM Pharma, Medpace Holdings, Inc., Merck KGaA, Pace Analytical Services, Inc., SGS SA, Societal CDMO, Source BioScience, Syneos Health, Thermo Fisher Scientific Inc., West Pharmaceutical Services, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Analytical Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Bioanalytical Testing
      • Clinical
      • Non-Clinical
    • Method Development & Validation
      • Extractable & Leachable
      • Impurity Method
      • Technical Consulting
    • Stability Testing
      • Accelerated Stability Testing
      • Drug Substance
      • Photostability Testing
      • Stability Indicating Method Validation
  • Testing Technique
    • Chromatography
    • Mass Spectrometry
    • Spectroscopy
  • End-use
    • Biopharmaceuticals & Pharmaceuticals
    • Contract Manufacturing Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pharmaceutical Analytical Testing Outsourcing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Analytical Testing Outsourcing Market?

3. What are the technology trends and regulatory frameworks in the Pharmaceutical Analytical Testing Outsourcing Market?

4. What is the market share of the leading vendors in the Pharmaceutical Analytical Testing Outsourcing Market?

5. Which modes and strategic moves are suitable for entering the Pharmaceutical Analytical Testing Outsourcing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research and development in drug discovery and development
      • 5.1.1.2. Complexity of drug formulations and need for compliance with stringent regulatory standards
      • 5.1.1.3. Growing preferences for pharmaceutical analytical testing outsourcing as a cost optimization strategy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of analytical instruments and maintaining state-of-the-art facilities
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technological advancements in drug testing procedures
      • 5.1.3.2. Increasing investments in the pharmaceutical industry
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with intellectual property rights
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Demand for bioanalytical testing services to determine efficacy and safety of pharmaceutical products
    • 5.2.2. Testing Technique: Significant benefits of chromatography owing to its efficiency in separating and quantifying analytes in samples
    • 5.2.3. End-use: Growing need for a broad range of high-complexity testing services from contract manufacturing organizations
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Pharmaceutical Analytical Testing Outsourcing Market, by Services

  • 6.1. Introduction
  • 6.2. Bioanalytical Testing
  • 6.3. Method Development & Validation
  • 6.4. Stability Testing

7. Pharmaceutical Analytical Testing Outsourcing Market, by Testing Technique

  • 7.1. Introduction
  • 7.2. Chromatography
  • 7.3. Mass Spectrometry
  • 7.4. Spectroscopy

8. Pharmaceutical Analytical Testing Outsourcing Market, by End-use

  • 8.1. Introduction
  • 8.2. Biopharmaceuticals & Pharmaceuticals
  • 8.3. Contract Manufacturing Organizations

9. Americas Pharmaceutical Analytical Testing Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Sterling Accuris expands into pharmaceutical and analytical testing through new acquisition
    • 12.3.2. Eurofins expands its biopharmaceutical products testing footprint with an outsourcing agreement with Astellas in Japan
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET DYNAMICS
  • FIGURE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS & PHARMACEUTICALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS & PHARMACEUTICALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN PHARMACEUTICAL ANALYT